Results 1 to 10 of about 29,231 (198)

Phosphoenolpyruvate carboxykinase in cell metabolism: Roles and mechanisms beyond gluconeogenesis [PDF]

open access: yesMolecular Metabolism, 2021
Background: Phosphoenolpyruvate carboxykinase (PCK) has been almost exclusively recognized as a critical enzyme in gluconeogenesis, especially in the liver and kidney.
Shuo Yu   +3 more
doaj   +3 more sources

The requirement of phosphoenolpyruvate carboxykinase 1 for angiogenesis in vitro and in vivo. [PDF]

open access: yesSci Adv, 2022
We here examined the potential biological function of phosphoenolpyruvate carboxykinase 1 (PCK1) in angiogenesis. shRNA- or CRISPR-Cas9–induced PCK1 depletion potently inhibited endothelial cell proliferation, migration, sprouting, and tube formation ...
Yao J   +10 more
europepmc   +2 more sources

Expanding the clinical spectrum of cytosolic phosphoenolpyruvate carboxykinase deficiency: novel PCK1 variants in four Arabian Gulf families [PDF]

open access: yesOrphanet Journal of Rare Diseases, 2023
Background In metabolic stress, the cytosolic phosphoenolpyruvate carboxykinase (PEPCK-C) enzyme is involved in energy production through the gluconeogenesis pathway.
Marwa Al Busaidi   +8 more
doaj   +2 more sources

Nur77 suppresses hepatocellular carcinoma via switching glucose metabolism toward gluconeogenesis through attenuating phosphoenolpyruvate carboxykinase sumoylation

open access: yesNature Communications, 2017
Gluconeogenesis is downregulated in hepatocellular carcinoma. Here, the authors show that nuclear receptor Nur77 acts as a tumour suppressor sustaining gluconeogenesis by enhancing phosphoenolpyruvate carboxykinase (PEPCK1) stability via regulating its ...
Xue-li Bian   +14 more
doaj   +2 more sources

Identification of phosphoenolpyruvate carboxykinase 1 as a potential therapeutic target for pancreatic cancer [PDF]

open access: yesCell Death and Disease, 2021
Pancreatic cancer is the third leading cause of cancer-related mortalities and is characterized by rapid disease progression. Identification of novel therapeutic targets for this devastating disease is important. Phosphoenolpyruvate carboxykinase 1 (PCK1)
Xiao-ren Zhu   +6 more
doaj   +2 more sources

Cytosolic phosphoenolpyruvate carboxykinase as a cataplerotic pathway in the small intestine.

open access: yesAm J Physiol Gastrointest Liver Physiol, 2018
Cytosolic phosphoenolpyruvate carboxykinase (PEPCK) is a gluconeogenic enzyme that is highly expressed in the liver and kidney but is also expressed at lower levels in a variety of other tissues where it may play adjunct roles in fatty acid ...
Potts A   +9 more
europepmc   +2 more sources

Expression and functional significance of phosphoenolpyruvate carboxykinase 1 in uveal melanoma [PDF]

open access: yesCell Death Discovery
Uveal melanoma (UVM), an uncommon yet potentially life-threatening ocular cancer, arises from melanocytes in the uveal tract of the eye. The exploration of novel oncotargets for UVM is of paramount importance.
Hui-e Bi   +6 more
doaj   +2 more sources

Discovery of PPi-type Phosphoenolpyruvate Carboxykinase Genes in Eukaryotes and Bacteria. [PDF]

open access: yesJ Biol Chem, 2015
Background: Inorganic pyrophosphate-type phosphoenolpyruvate carboxylase (PPi-PEPCK) was unidentified. Results: A conserved hypothetical protein was annotated as PPi-PEPCK.
Chiba Y   +4 more
europepmc   +2 more sources

Biallelic pathogenic variants in the mitochondrial form of phosphoenolpyruvate carboxykinase cause peripheral neuropathy [PDF]

open access: yesHGG Advances, 2023
Summary: Phosphoenolpyruvate carboxykinase (PCK) plays a critical role in cytosolic gluconeogenesis, and defects in PCK1 cause a fasting-aggravated metabolic disease with hypoglycemia and lactic acidosis.
Neal Sondheimer   +10 more
doaj   +2 more sources

Neddylation of phosphoenolpyruvate carboxykinase 1 controls glucose metabolism.

open access: yesCell Metab, 2023
Gonzalez-Rellan MJ   +27 more
europepmc   +2 more sources

Home - About - Disclaimer - Privacy